1. Chlorpromazine treatment was carried out with 53 female patients, 43 of whom were chronic schizophrenics. The dosage was high, up to 3,000 mgs. daily and the treatment lengthy, from six to eight months.
2. Among the chronic schizophrenic, remission occurred in 20% and Social Remission in 37% of the cases. Length of illness and grades of deterioration bear an inverse relationship to improvement.
3. Both paranoid and simplex schizophrenic patients benefitted from the treatment.
4. No permanent liver damage occurred. A large percentage of the previously positive CCF tests improved during the treatment and this was paralleled by psychological improvement.
References
1.
ArietiS.Interpretation of Schizophrenia.New York, Robert Brunner, 1955. p. 321–378.
2.
BellakL.Dementia Praecox.New York, Grune and Stratton, 1948. p. 31–32.
3.
DeutschL.Chlorpromazine and Mental Health, Philadelphia.Lea and Febiger, p. 61–62.
4.
Kinross-Wright, and MoyerJ. H.A.M.A.Archives of Neurology and Psychiatry.76, p. 675–680, 1956.
5.
Kinross-WrightVernon: The Intensive Chlorpromazine treatment of Schizophrenia, Psychiatric Research Report No. 1. American Psychiatric Association, 1955. p. 53–62.
6.
GaitzCharles, et alM.: Evaluation of Chlorpromazine in Comparison with Other Methods of Treatment of Hospitalized Psychiatric Patients, Using the Lorr Multidimensional Scale for Rating Psychiatric Patients. Psychiatric Research Report No. 1, American Psychiatric Association, 1955. p. 84–94.
